logo

IMMUCOR(NSDQ:BLUD)
Immucor is an international in vitro diagnostic company dedicated to automating manual processes in the hospital/donor laboratory. They develop, manufacture, and sell products used by hospital blood banks, clinical laboratories, and large blood-donor centers to test, detect, and identify certain properties of human blood prior to patient transfusion. Immucor''s instruments utilize patented solid phase technology reagents to perform ABO grouping tests, RH typing, antibody screening, and platelet cross-matching.
# Employees: 729
Address: 3130 Gateway Drive P.O. Box 5625,Norcross,GA,USA
Phone: 770 441-2051
Fax: 770 441-3807
Website: www.immucor.com
Email: info@immucor.com
Sector: Medical
Industry: MED/DENTAL-SUPP
Executive Officers
Michael Goldman (Dir.)
Gioacchino De chirico Dr. (Presi.; Dir.)
Ralph A. Eatz (Dir.)
Richard A. Flynt (V.P.; C.F.O.)
Roswell S. Bowers (Dir.,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 8/31/2009
Next Earnings Date(Expected): 1/6/2010
Mean EPS (Next Qtr): $0.26
Mean EPS (Year): $1.15
Mean Estimate(Long Term): $15.67
P/E Ratio(Based on EPS estimate): 16.270
Number of Estimates: 8
Shares Performance
Period BLUD Compare to S&P
YTD -29.38 % -41.56 %
4 Weeks 4.10 % 2.98 %
12 Weeks 2.74 % -3.14 %
Shares Information
Analyst Coverage: Y
Avg Volume: 607668
Shares Outstanding: 70M
Market Cap: $1.32B
52 Week High: $28.86
52 Week Low: $13.30
P/E Ratio: 17.060
PEG Ratio: 1.040
Split: On 5/16/2006 BLUD split by factor of 1.500
Earnings Performance
EPS Growth in Last Quarter: 3.45 %
EPS Growth in Last Year: 7.14 %
Sales Growth in Last Quarter: 5.10 %
Sales Growth in Last Quarter: 13.52 %
Financials
Qtr Book Value: $3.29
Cash Flow/Share: $14.55
Change in Payout Ratio: 0.000
Price/Sales: 4.240
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia